Carole Ho Royalty Pharma PLC (RPRX) insider trading activity

RPRX Quotes by TradingView

Carole Ho is Director of Royalty Pharma plc. Currently has a direct ownership of 8,558 shares of RPRX, which is worth approximately $306,889. The most recent transaction as insider was on Jul 31, 2025, when has been sold 8,558 shares (Class A Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.56K
n/a 3M change
n/a 12M change
Total Value Held $306,889

Carole Ho Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 31 2025
BUY
Grant, award, or other acquisition
-
8,558 Added 50.0%
8,558 Class A Ordinary Shares

Also insider at

DNLI
Denali Therapeutics Inc. Healthcare
Chief Medical Officer
NGM
NGM BIOPHARMACEUTICALS INC Healthcare
BEAM
Beam Therapeutics Inc. Healthcare
CH

Carole Ho

Director
Cambridge, MA

Track Institutional and Insider Activities on RPRX

Follow Royalty Pharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPRX shares.

Notify only if

Insider Trading

Get notified when an Royalty Pharma PLC insider buys or sells RPRX shares.

Notify only if

News

Receive news related to Royalty Pharma plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RPRX